English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Sep 16, 2024

UTHealth Houston president Giuseppe N. Colasurdo announces resignation after twelve years
+ Pharmaceuticals
Patient Daily | Sep 16, 2024

UTHealth collaborates with The Ocean Corporation on new fellowship program
+ Pharmaceuticals
Patient Daily | Sep 16, 2024

Understanding sepsis: Causes, symptoms, treatment options
+ Pharmaceuticals
Patient Daily | Sep 16, 2024

First patient enrolled at UTHealth Houston for neural cell therapy study on epilepsy
+ Pharmaceuticals
Patient Daily | Sep 16, 2024

Managing workplace anxiety: Expert advice on triggers and solutions
+ Pharmaceuticals
Patient Daily | Sep 16, 2024

Karen Undieme celebrates three years cancer-free with LUNG FORCE Walk
+ Pharmaceuticals
Patient Daily | Sep 13, 2024

UTHealth Houston collaborates with OpenAI on AI integration in healthcare
+ Community
Patient Daily | Sep 12, 2024

Synergy Surgical sponsoring Hospital Supply Chain conference in Las Vegas

Trending
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns